Strainsforpains Valuation
EBYH Stock | USD 0.23 0.00 0.00% |
Strainsforpains seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of Strainsforpains from inspecting the company fundamentals such as Book Value Per Share of (2.94) X, cash and equivalents of 2.29 K, and Current Valuation of 1.56 M as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Strainsforpains' price fluctuation is out of control at this time. Calculation of the real value of Strainsforpains is based on 3 months time horizon. Increasing Strainsforpains' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Strainsforpains is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Strainsforpains Pink Sheet. However, Strainsforpains' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 0.23 | Real 0.2 | Hype 0.23 | Naive 0.24 |
The intrinsic value of Strainsforpains' stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Strainsforpains' stock price.
Estimating the potential upside or downside of Strainsforpains helps investors to forecast how Strainsforpains pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Strainsforpains more accurately as focusing exclusively on Strainsforpains' fundamentals will not take into account other important factors: Strainsforpains Total Value Analysis
Strainsforpains is currently anticipated to have valuation of 1.56 M with market capitalization of 1.78 M, debt of 1.81 M, and cash on hands of 2.29 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Strainsforpains fundamentals before making equity appraisal based on enterprise value of the companyTakeover Price | Market Cap | Debt Obligations | Cash |
1.56 M | 1.78 M | 1.81 M | 2.29 K |
Strainsforpains Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The recent return on assets of Strainsforpains signifies not a very effective usage of assets in December.Strainsforpains Profitability Analysis
Net Loss for the year was (66.08 K) with profit before overhead, payroll, taxes, and interest of 0.About Strainsforpains Valuation
An absolute valuation paradigm, as applied to Strainsforpains Pink Sheet, attempts to find the value of Strainsforpains based on its fundamental and basic technical indicators. By analyzing Strainsforpains's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Strainsforpains's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Strainsforpains. We calculate exposure to Strainsforpains's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Strainsforpains's related companies.Strainsforpains, Inc. operates as a medical marijuana data recommendation system. The company was incorporated in 1990 and is based in New York, New York. E-Buy Home operates under Health Information Services classification in the United States and is traded on OTC Exchange.
8 Steps to conduct Strainsforpains' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Strainsforpains' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Strainsforpains' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Strainsforpains' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Strainsforpains' revenue streams: Identify Strainsforpains' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Strainsforpains' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Strainsforpains' growth potential: Evaluate Strainsforpains' management, business model, and growth potential.
- Determine Strainsforpains' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Strainsforpains' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Strainsforpains Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Retained Earnings | -1.9 M |
Complementary Tools for Strainsforpains Pink Sheet analysis
When running Strainsforpains' price analysis, check to measure Strainsforpains' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Strainsforpains is operating at the current time. Most of Strainsforpains' value examination focuses on studying past and present price action to predict the probability of Strainsforpains' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Strainsforpains' price. Additionally, you may evaluate how the addition of Strainsforpains to your portfolios can decrease your overall portfolio volatility.
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |